the effects of hydroxychloroquine and sulphasalazine on progression of joint damage shown by x-rays were compared in a double-blind , randomised trial in 60 patients with rheumatoid arthritis not previously treated with slow-acting antirheumatic drugs .
C0020336
hydroxychloroquine
C0003191
antirheumatic drugs